INDICATION AND USAGE Hypertension.
From the U.S. FDA-approved label for Methyldopa. Full label: DailyMed.
ADULTS Initiation of Therapy The usual starting dosage of Methyldopa is 250 mg two or three times a day in the first 48 hours. The daily dosage then may be increased or decreased, preferably at intervals of not less than two days, until an adequate response is achieved. To minimize the sedation, start dosage increases in the evening.
Directions from the U.S. FDA-approved label for Methyldopa — your doctor or pharmacist may advise differently.
Methyldopa is contraindicated in patients: — with active hepatic disease, such as acute hepatitis and active cirrhosis — with liver disorders previously associated with methyldopa therapy ( see WARNINGS ) — with hypersensitivity to any component of these products. — on therapy with monoamine oxidase (MAO) inhibitors.
Excerpt from the U.S. FDA-approved label for Methyldopa. Talk to a pharmacist or doctor before use.
It is important to recognize that a positive Coombs test, hemolytic anemia, and liver disorders may occur with methyldopa therapy. The rare occurrences of hemolytic anemia or liver disorders could lead to potentially fatal complications unless properly recognized and managed. Read this section carefully to understand these reactions. With prolonged methyldopa therapy, 10 to 20 percent of patients develop a positive direct Coombs test which usually occurs between 6 and 12 months of methyldopa therapy. Lowest incidence is at daily dosage of 1 g or less.
Warnings and precautions excerpt from the U.S. FDA-approved label for Methyldopa — not a complete list. Talk to a pharmacist or doctor before use.
Sedation, usually transient, may occur during the initial period of therapy or whenever the dose is increased. Headache, asthenia, or weakness may be noted as early and transient symptoms. However, significant adverse effects due to Methyldopa have been infrequent and this agent usually is well tolerated. The following adverse reactions have been reported and, within each category, are listed in order of decreasing severity.
Excerpt from the U.S. FDA-approved label for Methyldopa — not a complete list. Talk to a pharmacist or doctor about side effects.
Storage Store Methyldopa Tablets at controlled room temperature 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label for Methyldopa.
What is Alphadopa?
Alphadopa Tablet is a Methyldopa medicine made by Wockhardt Ltd. It comes as Tablet.
What is Alphadopa used for?
According to its FDA label, Methyldopa is INDICATION AND USAGE Hypertension.
What is the generic name of Alphadopa?
The generic name of Alphadopa is Methyldopa.
What are the side effects of Methyldopa?
Sedation, usually transient, may occur during the initial period of therapy or whenever the dose is increased. Headache, asthenia, or weakness may be noted as early and transient symptoms. However, significant adverse effects due to Methyldopa have been infrequent and this agent usually is well tolerated.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
